IMU 6.78% 5.5¢ imugene limited

Ann: New Cancer Vaccine Trial Data presented at ASCO 2019, page-2

  1. 12,248 Posts.
    lightbulb Created with Sketch. 3747
    Just to silence all those who wrote IMU is crap:

    1. " The study is ongoing with patients continuing to receive HER-Vaxx every 3 months to maintain highlevels of cancer targeting antibodies."

    Without HER-Vaxx they would be dead already and look, some are still alive and kicking - what more proof does anyone need to see that the immune system got stimulated in a way that is had secured survival !!!!!!!!!!!!!

    2. " Imugene Managing Director and Chief Executive Officer Leslie Chong said, “There is continuedinterest in the positive data from our Phase Ib trial which clearly supports our B-cell platformcancer vaccine strategy for treating HER-2 positive gastric cancer.”

    I trust IMU comments only, that's what my investment is based on.

    GLTA and there is finally a real chance for a cure !!!!!!!!!!!!!
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.5¢
Change
-0.004(6.78%)
Mkt cap ! $409.9M
Open High Low Value Volume
6.0¢ 6.1¢ 5.5¢ $2.458M 43.26M

Buyers (Bids)

No. Vol. Price($)
5 131956 5.5¢
 

Sellers (Offers)

Price($) Vol. No.
5.6¢ 524513 13
View Market Depth
Last trade - 15.21pm 24/06/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.